Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 169 |
|
|||||
| News | - | ||||||
| Day High | 4.49 | Low High |
|||||
| Day Low | 4.49 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Edesa Biotech Inc | EDSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.025 | 0.56% | 4.49 | 09:33:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.49 | 4.49 | 4.49 | 4.465 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 7 | 169 | - | 2.4603 - 8.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:32:43 | 11 | $ 4.47 | USD |
Edesa Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.24M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Edesa Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.36 | 4.7255 | 4.2501 | 4.43 | 1,504 | 0.13 | 2.98% |
| 1 Month | 4.30 | 4.9566 | 4.0165 | 4.46 | 6,292 | 0.19 | 4.42% |
| 3 Months | 4.41 | 5.99 | 3.88 | 4.84 | 12,489 | 0.08 | 1.81% |
| 6 Months | 3.30 | 6.46 | 2.50 | 4.40 | 21,503 | 1.19 | 36.06% |
| 1 Year | 7.56 | 8.61 | 2.4603 | 5.25 | 64,696 | -3.07 | -40.61% |
| 3 Years | 38.85 | 84.00 | 2.4603 | 58.45 | 395,586 | -34.36 | -88.44% |
| 5 Years | 36.05 | 133.70 | 2.4603 | 54.06 | 412,431 | -31.56 | -87.55% |
Edesa Biotech Description
| Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. |
